Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Expert Opinion on Pharmacotherapy|March 17, 2015
Changes and determination of dosing recommendations for medicinal products recently authorised in the European UnionFalk Ehmann, Marisa Papaluca, Francesca Di Giuseppe, et al.
Paediatric Anaesthesia|January 20, 2011
Role of modeling and simulation in pediatric investigation plansEfthymios Manolis, Tariq Eldirdiry Osman, Ralf Herold, et al.
British Journal of Clinical Pharmacology|October 22, 2009
Proposals for model-based paediatric medicinal development within the current European Union regulatory frameworkEfthymios Manolis, Gérard Pons
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2015
Hollow Fiber System Model for Tuberculosis: The European Medicines Agency ExperienceMarco Cavaleri, Efthymios Manolis
Proteomics. Clinical Applications|May 4, 2011
New pathway for qualification of novel methodologies in the European Medicines AgencyEfthymios Manolis, Spiros Vamvakas, Maria Isaac
Journal of Clinical Pharmacology|June 29, 2021
The European Medicines Agency Experience With Pediatric Dose SelectionEfthymios Manolis, Flora T Musuamba, Kristin E Karlsson
Methods in Molecular Biology (Clifton, N.J.)|November 12, 2014
The European Medicines Agency experience with biomarker qualificationEfthymios Manolis, Armin Koch, Dieter Deforce, et al.
International Journal of Medical Informatics|August 12, 2003
Qumquad: a UML-based approach for remodeling of legacy systems in health careSebastian Garde, Petra Knaup, Ralf Herold
Pageof 4